Etana Biotechnologies Indonesia Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
435
- Latest Deal Type
-
Later Stage VC
- (Upcoming)
- Latest Deal Amount
-
$30M
- Investors
-
8
Etana Biotechnologies Indonesia General Information
Description
Operator of a biotech company intended to manufacture biosimilars for Indonesia and other emerging countries. The company engages in the development and commercialization of biological drugs in the oncology field and other life-threatening diseases and in the manufacturing, R&D, and marketing of recombinant gene technology and monoclonal antibody drugs, providing patients with affordable medicines and vaccines.
Contact Information
Website
www.id.etanabiotech.comCorporate Office
- Kawasan Industri Pulogadung
- Jl. Rawa Gelam V Blok L Kav. 11-13, Jatinegara, Cakung
- East Jakarta, 13930
- Indonesia
Corporate Office
- Kawasan Industri Pulogadung
- Jl. Rawa Gelam V Blok L Kav. 11-13, Jatinegara, Cakung
- East Jakarta, 13930
- Indonesia
Etana Biotechnologies Indonesia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | $30M | Upcoming | Generating Revenue | |||
| 3. Later Stage VC | 20-Mar-2023 | Completed | Generating Revenue | |||
| 2. Later Stage VC (Series B) | 28-Sep-2022 | Completed | Generating Revenue | |||
| 1. Later Stage VC (Series A) | 14-Sep-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Etana Biotechnologies Indonesia Comparisons
Industry
Financing
Details
Etana Biotechnologies Indonesia Competitors (69)
One of Etana Biotechnologies Indonesia’s 69 competitors is BeOne Medicines, a Formerly PE-Backed company based in Beijing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BeOne Medicines | Formerly PE-Backed | Beijing, China | ||||
| Alphamab Oncology | Formerly VC-backed | Suzhou, China | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA | ||||
| AB Science | Formerly Accelerator/Incubator backed | Paris, France | ||||
| Brii Biosciences | Formerly VC-backed | Beijing, China |
Etana Biotechnologies Indonesia Signals
Etana Biotechnologies Indonesia Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DEG | PE/Buyout | Minority | ||
| East Ventures | Venture Capital | Minority | ||
| China Medical System Holdings | Corporation | Minority | ||
| Highlight Capital | Venture Capital | Minority | ||
| Yunfeng Capital | PE/Buyout | Minority |
Etana Biotechnologies Indonesia FAQs
-
When was Etana Biotechnologies Indonesia founded?
Etana Biotechnologies Indonesia was founded in 2014.
-
Where is Etana Biotechnologies Indonesia headquartered?
Etana Biotechnologies Indonesia is headquartered in East Jakarta, Indonesia.
-
What is the size of Etana Biotechnologies Indonesia?
Etana Biotechnologies Indonesia has 435 total employees.
-
What industry is Etana Biotechnologies Indonesia in?
Etana Biotechnologies Indonesia’s primary industry is Biotechnology.
-
Is Etana Biotechnologies Indonesia a private or public company?
Etana Biotechnologies Indonesia is a Private company.
-
What is Etana Biotechnologies Indonesia’s current revenue?
The current revenue for Etana Biotechnologies Indonesia is .
-
Who are Etana Biotechnologies Indonesia’s investors?
DEG, East Ventures, China Medical System Holdings, Highlight Capital, and Yunfeng Capital are 5 of 8 investors who have invested in Etana Biotechnologies Indonesia.
-
Who are Etana Biotechnologies Indonesia’s competitors?
BeOne Medicines, Alphamab Oncology, Genetix Biotherapeutics, AB Science, and Brii Biosciences are some of the 69 competitors of Etana Biotechnologies Indonesia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process